Management of ALL in adults: 2024 ELN recommendations from a European expert panel

Author:

Gökbuget Nicola1ORCID,Boissel Nicolas2ORCID,Chiaretti Sabina3,Dombret Hervé4,Doubek Michael5ORCID,Fielding Adele6ORCID,Foà Robin3,Giebel Sebastian7ORCID,Hoelzer Dieter1,Hunault Mathilde8ORCID,Marks David I.9,Martinelli Giovanni10,Ottmann Oliver11,Rijneveld Anita12,Rousselot Philippe13,Ribera Josep14ORCID,Bassan Renato15ORCID

Affiliation:

1. 1Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany

2. 2Hospital Saint-Louis, Assistance Publique–Hôpitaux de Paris, Paris, France

3. 3Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy

4. 4Leukemia Department, University Hospital Saint-Louis, Assistance Publique–Hôpitaux de Paris, Saint-Louis Research Institute, Université Paris Cité, Paris, France

5. 5Department of Internal Medicine–Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

6. 6UCL Cancer Institute, London, United Kingdom

7. 7Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland

8. 8Maladies du Sang University Hospital of Angers, FHU Goal, INSERM, National Centre for Scientific Research, Angers, France

9. 9University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

10. 10IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy

11. 11Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom

12. 12Erasmus MC Cancer Institute, Rotterdam, The Netherlands

13. 13Clinical Hematology Department, Centre Hospitalier de Versailles, Université Paris-Saclay, Versailles, France

14. 14Clinical Hematology Department, Institut Catala d'Oncologia Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain

15. 15Division of Hematology, Ospedale dell’Angelo, Mestre-Venice, Italy

Abstract

Abstract Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.

Publisher

American Society of Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3